Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool aims to unmask why sleep apnea patients abandon their breathing machines

NCT ID NCT05530967

Knowledge-focused Sponsor: Kaiser Permanente Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests a questionnaire called the PAP Problems Triaging Tool, designed to identify why people with obstructive sleep apnea struggle to use their positive airway pressure (PAP) machines. Researchers will ask adults newly prescribed PAP therapy to complete the questionnaire at days 5, 10, and 30, and will track their actual machine use. The goal is to see if the tool can predict who will stop using their device, so that targeted help can be offered early.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a questionnaire (PAP Problems Triaging Tool) and video education
What this could lead to
If validated, this tool could help doctors quickly identify and address specific problems patients have with PAP therapy, potentially improving long-term adherence and sleep apnea outcomes.
What could go wrong
This is an observational validation study, not a treatment trial. The tool may not accurately predict adherence in all patients, and the findings may not apply outside the specific health system studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

355 people

The number who actually took part.

Started

Feb 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Kaiser Permanente Member (KP insured) * OSA diagnosis by polysomnogram or Home Sleep Apnea Test with Apnea Hypopnea Index ≥ 15 events/hour * PAP naïve * Able to consent to participate * Fluent or proficient with English * Accepts PAP for home treatment Exclusion Criteria: * Chronic respiratory failure requiring Oxygen supplementation * PAP device other than a PAP or AutoPAP (i.e., bilevel PAP) * Pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea (OSA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructive sleep apnea (OSA)

Contacts and locations

Locations

  • Kaiser Permanente Fontana Sleep Clinic

    Fontana, California, 92335, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.